Jörg Hoffmann, MD

St. Marienkrankenhaus
Ludwigshafen Germany Papers:
T.90 Targeting human CD2 by the monoclonal Antibody CB.219 reduces intestinal Inflammation in a humanized Transfer Colitis Model